ROLE OF APE1/REF-1 IN CARDIOVASCULAR DISEASES
Keywords:
APE1/Ref-1, cardiovascular diseases, base excision repair, redox regulationAbstract
Apurinic/apyrimidinic endonuclease 1/redox effector factor-1 (APE1/Ref-1) is a multifunctional protein involved in the DNA base excision repair pathway, redox regulation, inflammation, and survival pathways. APE1/Ref-1 could inhibit the production of reactive oxygen species (ROS). Excessive ROS production could lead to DNA damage and cell apoptosis, which is viewed as the cause of cardiovascular diseases. Recent advances of molecular studies have demonstrated that APE1/Ref-1 is involved in the pathogenesis of cardiovascular diseases. In this review, we will introduce the multifunctional role of APE1/Ref-1 and its potential usefulness as a therapeutic target in cardiovascular diseases.References
[1] Bhakat KK, Mantha AK, Mitra S. Transcriptional Regulatory Functions of Mammalian APEndonuclease (APE1/Ref-1), an Essential Multifunctional Protein. Antioxid Redox Signal 2009; 11 (3): 621-37.
[2] Bauer CE, Elsen S, Bird TH. Mechanisms for redox control of gene expression. Annu Rev Microbiol 1999; 53: 495-523. eng.
[3] Tell G, Quadrifoglio F, Tiribelli C, Kelley MR. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009; 11 (3): 601-20. eng.
[4] Xanthoudakis S, Miao GG, Curran T. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc Natl Acad Sci USA 1994; 91 (1): 23-27. eng.
[5] Choi S, Joo HK, Jeon BH. Dynamic Regulation of APE1/Ref- 1 as a Therapeutic Target Protein. Chonnam Med J 2016; 52 (2): 75- 80.
[6] Moris D, Spartalis M, Spartalis E, Karachaliou G-S, Karaolanis GI, Tsourouflis G, et al. The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox. Annals of Translational Medicine 2017; 5 (16). en.
[7] Hegde ML, Mantha AK, Hazra TK, Bhakat KK, Mitra S, Szczesny B. Oxidative genome damage and its repair: implications in aging and neurodegenerative diseases. Mech Ageing Dev 2012; 133 (4): 157-68. eng.
[8] Thakur S, Dhiman M, Tell G, Mantha AK. A review on proteinprotein interaction network of APE1/Ref-1 and its associated biological functions. Cell Biochem Funct 2015; 33 (3): 101-12. eng.
[9] Mol CD, Izumi T, Mitra S, Tainer JA. DNA-bound structures and mutants reveal abasic DNA binding by APE1 and DNA repair coordination [corrected]. Nature 2000; 403 (6768): 451-56. eng.
[10] Kanazhevskaya LY, Koval VV, Zharkov DO, Strauss PR, Fedorova OS. Conformational transitions in human AP endonuclease 1 and its active site mutant during abasic site repair. Biochemistry 2010; 49 (30): 6451-61. eng.
[11] Jackson EB, Theriot CA, Chattopadhyay R, Mitra S, Izumi T. Analysis of nuclear transport signals in the human apurinic/apyrimidinic endonuclease (APE1/Ref1). Nucleic Acids Res 2005; 33 (10): 3303-12. eng.
[12] Chattopadhyay R, Das S, Maiti AK, Boldogh I, Xie J, Hazra TK, et al. Regulatory role of human APendonuclease (APE1/Ref-1) in YB- 1-mediated activation of the multidrug resistance gene MDR1. Mol Cell Biol 2008; 28 (23): 7066- 80. eng.
[13] Luo M, Zhang J, He H, Su D, Chen Q, Gross ML, et al. Characterization of the redox activity and disulfide bond formation in apurinic/apyrimidinic endonuclease. Biochemistry 2012; 51 (2): 695-705. eng.
[14] Cesselli D, Aleksova A, Sponga S, Cervellin C, Di Loreto C, Tell G, et al. Cardiac Cell Senescence and Redox Signaling. Front Cardiovasc Med 2017; 4.Thakur S, Sarkar B, Cholia RP, Gautam N, Dhiman M, Mantha AK. APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions. Experimental & Molecular Medicine 2014; 46 (7): e106.
[15] Beckman KB, Ames BN. Oxidative decay of DNA. J Biol Chem 1997; 272 (32): 19633-
[16] Slupphaug G, Kavli B, Krokan HE. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res 2003; 531 (1-2): 231-51. eng.
[17] Hegde ML, Hazra TK, Mitra S. Early Steps in the DNA Base Excision/Single-Strand Interruption Repair Pathway in Mammalian Cells. Cell Res 2008; 18 (1): 27-47.
[18] Doetsch PW, Cunningham RP. The enzymology of apurinic/apyrimidinic endonucleases. Mutat Res 1990; 236 (2-3): 173-201. eng.
[19] Xanthoudakis S, Miao G, Wang F, Pan YC, Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 1992; 11 (9): 3323-35. eng.
[20] Abate C, Patel L, Rauscher FJ, Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 1990; 249 (4973): 1157-61. eng.
[21] Guan Z, Basi D, Li Q, Mariash A, Xia Y-F, Geng J-G, et al. Loss of redox factor 1 decreases NFkappaB activity and increases susceptibility of endothelial cells to apoptosis. Arterioscler Thromb Vasc Biol 2005; 25 (1): 96-101. eng.
[22] Martin KR, Barrett JC. Reactive oxygen species as double-edged swords in cellular processes: lowdose cell signaling versus highdose toxicity. Hum Exp Toxicol 2002; 21 (2): 71-75. eng.
[23] Ramana CV, Boldogh I, Izumi T, Mitra S. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci USA 1998; 95 (9): 5061-66. eng.
[24] Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 1997; 11 (5): 558-